NO20015814D0 - Metallkompleksforbindelser - Google Patents

Metallkompleksforbindelser

Info

Publication number
NO20015814D0
NO20015814D0 NO20015814A NO20015814A NO20015814D0 NO 20015814 D0 NO20015814 D0 NO 20015814D0 NO 20015814 A NO20015814 A NO 20015814A NO 20015814 A NO20015814 A NO 20015814A NO 20015814 D0 NO20015814 D0 NO 20015814D0
Authority
NO
Norway
Prior art keywords
metal complex
complex compounds
vivo
nmr
mri
Prior art date
Application number
NO20015814A
Other languages
English (en)
Inventor
Jo Klaveness
Paal Rongved
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Priority to NO20015814A priority Critical patent/NO20015814D0/no
Publication of NO20015814D0 publication Critical patent/NO20015814D0/no
Priority to AU2002365365A priority patent/AU2002365365A1/en
Priority to US10/496,852 priority patent/US7198776B2/en
Priority to EP02803942A priority patent/EP1465669B1/en
Priority to PCT/NO2002/000453 priority patent/WO2003045442A1/en
Priority to DE60223176T priority patent/DE60223176T2/de
Priority to AT02803942T priority patent/ATE376428T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
NO20015814A 2001-11-28 2001-11-28 Metallkompleksforbindelser NO20015814D0 (no)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NO20015814A NO20015814D0 (no) 2001-11-28 2001-11-28 Metallkompleksforbindelser
AU2002365365A AU2002365365A1 (en) 2001-11-28 2002-11-28 Metal complex compounds
US10/496,852 US7198776B2 (en) 2001-11-28 2002-11-28 Metal complex compounds
EP02803942A EP1465669B1 (en) 2001-11-28 2002-11-28 Metal complex compounds
PCT/NO2002/000453 WO2003045442A1 (en) 2001-11-28 2002-11-28 Metal complex compounds
DE60223176T DE60223176T2 (de) 2001-11-28 2002-11-28 Metallkomplexverbindungen
AT02803942T ATE376428T1 (de) 2001-11-28 2002-11-28 Metallkomplexverbindungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20015814A NO20015814D0 (no) 2001-11-28 2001-11-28 Metallkompleksforbindelser

Publications (1)

Publication Number Publication Date
NO20015814D0 true NO20015814D0 (no) 2001-11-28

Family

ID=19913076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015814A NO20015814D0 (no) 2001-11-28 2001-11-28 Metallkompleksforbindelser

Country Status (7)

Country Link
US (1) US7198776B2 (no)
EP (1) EP1465669B1 (no)
AT (1) ATE376428T1 (no)
AU (1) AU2002365365A1 (no)
DE (1) DE60223176T2 (no)
NO (1) NO20015814D0 (no)
WO (1) WO2003045442A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7303871B2 (en) * 2002-02-14 2007-12-04 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
US7776545B2 (en) * 2002-11-20 2010-08-17 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic method for Celiac Sprue
WO2003096979A2 (en) * 2002-05-14 2003-11-27 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
US7265093B2 (en) * 2002-05-14 2007-09-04 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
US7462688B2 (en) * 2002-05-14 2008-12-09 The Board Of Trustees Of The Leland Stanford Junior University Peptides for diagnostic and therapeutic methods for celiac sprue
US7202216B2 (en) * 2002-05-14 2007-04-10 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
US7640052B2 (en) 2004-05-28 2009-12-29 Ippp, Llc Method of integrated proton beam and therapeutic magnetic resonance therapy
US7801585B1 (en) * 2003-06-02 2010-09-21 Newlife Sciences Llc System for analyzing and treating abnormality of human and animal tissues
US7579313B2 (en) * 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
US7628985B2 (en) * 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US8108047B2 (en) 2005-11-08 2012-01-31 Newlife Sciences Llc Device and method for the treatment of pain with electrical energy
US20080109049A1 (en) * 2006-11-08 2008-05-08 Schumann Daniel H Device & method for relieving pain
CA2680590C (en) * 2007-03-16 2017-10-17 Jonathan David Gass Combination enzyme therapy for digestion of dietary gluten
GB0708411D0 (en) * 2007-05-01 2007-06-06 Univ Durham Lanthanide probes
US20090149732A1 (en) * 2007-12-08 2009-06-11 Weinstock Ronald J System for use of electrical resonant frequencies in analyzing and treating abnormality of human and animal tissues
US20100324627A1 (en) * 2008-07-28 2010-12-23 Newlife Sciences, Llc Method and apparatus for resistivity measurement, detection and treatment in living tissue
WO2010056590A2 (en) * 2008-11-14 2010-05-20 University Of Maryland, Baltimore Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging
WO2012074794A2 (en) 2010-11-30 2012-06-07 Newlife Sciences Llc Apparatus and method for treatment of pain with body impedance analyzer
EP3983051A1 (en) 2019-06-12 2022-04-20 Truerelief, LLC System and method for delivering pulsed electric current to living tissue
US11911605B2 (en) 2021-03-05 2024-02-27 Truerelief Llc Method and apparatus for injury treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (de) 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
JPH0797340A (ja) * 1993-06-03 1995-04-11 Terumo Corp Ｍｒｉ造影剤組成物
US5707605A (en) 1995-06-02 1998-01-13 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US5980862A (en) 1995-06-02 1999-11-09 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
DE19603033A1 (de) 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
EP1032430A2 (en) 1997-11-17 2000-09-06 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the detection of physiological agents

Also Published As

Publication number Publication date
US7198776B2 (en) 2007-04-03
AU2002365365A1 (en) 2003-06-10
US20050090653A1 (en) 2005-04-28
EP1465669A1 (en) 2004-10-13
DE60223176D1 (de) 2007-12-06
EP1465669B1 (en) 2007-10-24
WO2003045442A1 (en) 2003-06-05
DE60223176T2 (de) 2008-08-07
ATE376428T1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
DE60223176D1 (de) Metallkomplexverbindungen
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
DE60206512D1 (de) Rapanycin29-enole
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
AU2003205077A1 (en) Imaging agents and methods of imaging naaladase of psma
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
WO2002044156A3 (en) Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
ATE470723T1 (de) Genexpressionsmarker für die prognose von brustkrebs
HUP0301835A2 (hu) Kationos diagnosztikai, képalkotó és terápiás ágensek, aktivált vaszkuláris helyekkel asszociálódva
NO991688D0 (no) Administrerbare sammensetninger og fremgangsmÕter til magnetisk resonansavbildning
MX2007013834A (es) Terapias de enfermedades vasculares.
CY1108540T1 (el) Ταυτοποιηση θεραπευτικων ενωσεων
GB2388190B (en) Methods for measuring enzyme activity
DE60032784D1 (de) Markerproteine für prostatakrebs
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE69913533D1 (de) Reagentien für cyp2d fluoreszenztest
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ATE337020T1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
ATE281455T1 (de) Oxindolderivate
SE0202608D0 (sv) New sequences
WO2008014296A3 (en) Composition and method for treatment of tumors
EP1492880A4 (en) EX-VIVO METHOD FOR DETERMINING THE CETP ACTIVITY AND EFFECTIVENESS OF THE TREATMENT OF HERZER DISEASES
WO2005019427A3 (en) Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals
WO2003020294A8 (de) Markierung der aromatase
ATE389657T1 (de) Diaminopyrrolochinazoline als protein-tyrosin- phosphatase-inhibitoren